Next Article in Journal
Editorial of Special Issue “Rare Kidney Diseases: New Translational Research Approach to Improve Diagnosis and Therapy”
Previous Article in Journal
A Flowable Placental Formulation Prevents Bleomycin-Induced Dermal Fibrosis in Aged Mice
Previous Article in Special Issue
Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 21
Issue 12
10.3390/ijms21124243
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Int. J. Mol. Sci. 2019, 20(11), 2802.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Fararjeh, A-F S., et al. ZBTB46, SPDEF, ETV6 Novel Potential Biomarkers and Therapeutic Targets in Castration Resistance Prostate Cancer. Int. J. Mol. Sci. 2019, 20, 2802

by
Abdul-Fattah Salah Fararjeh
1 and
Yen-Nien Liu
2,3,*
1
Department of Medical Laboratory Sciences, Faculty of Science, Al-Balqa Applied University, Al-Salt 19117, Jordan
2
Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan
3
Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(12), 4243; https://doi.org/10.3390/ijms21124243
Submission received: 25 May 2020 / Accepted: 27 May 2020 / Published: 14 June 2020
(This article belongs to the Special Issue Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer 2019)
Versions Notes
The authors wish to make the following correction to this paper [1]: PSA, which was described as being initiated in “1979”, was actually initiated in “1970”.
The authors would like to apologize for any inconvenience caused to the readers by this change.

Reference

  1. Fararjeh, A.-F.S.; Liu, Y.N. ZBTB46, SPDEF, ETV6 novel potential biomarkers and therapeutic targets in castration resistance prostate cancer. Int. J. Mol. Sci. 2019, 20, 2802. [Google Scholar] [CrossRef] [PubMed] [Green Version]

Share and Cite

MDPI and ACS Style

Fararjeh, A.-F.S.; Liu, Y.-N. Correction: Fararjeh, A-F S., et al. ZBTB46, SPDEF, ETV6 Novel Potential Biomarkers and Therapeutic Targets in Castration Resistance Prostate Cancer. Int. J. Mol. Sci. 2019, 20, 2802. Int. J. Mol. Sci. 2020, 21, 4243. https://doi.org/10.3390/ijms21124243

AMA Style

Fararjeh A-FS, Liu Y-N. Correction: Fararjeh, A-F S., et al. ZBTB46, SPDEF, ETV6 Novel Potential Biomarkers and Therapeutic Targets in Castration Resistance Prostate Cancer. Int. J. Mol. Sci. 2019, 20, 2802. International Journal of Molecular Sciences. 2020; 21(12):4243. https://doi.org/10.3390/ijms21124243

Chicago/Turabian Style

Fararjeh, Abdul-Fattah Salah, and Yen-Nien Liu. 2020. "Correction: Fararjeh, A-F S., et al. ZBTB46, SPDEF, ETV6 Novel Potential Biomarkers and Therapeutic Targets in Castration Resistance Prostate Cancer. Int. J. Mol. Sci. 2019, 20, 2802" International Journal of Molecular Sciences 21, no. 12: 4243. https://doi.org/10.3390/ijms21124243

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop